Fresh analysis reveals that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop traditional diet and exercise regimens.
Published data in a major health publication shows that while overweight individuals often shed a large proportion of their body weight while using the jabs, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.
"Users buying these treatments should be informed of the potential of rapid rebound weight gain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a return to starting weight in about 18 months.
Comparing Approaches
The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers note that people who lose weight through lifestyle changes alone usually have a more gradual creep back—around 0.1 kg a month—post-intervention.
Understanding the Quick Rebound
Doctors suggest the mode of action of the drugs accounts for the amplified regain.
The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating much more probable."
An Ongoing Condition?
The NHS suggest the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the high risk of relapse, the treatment might need to be ongoing.
This view is reinforced by drug manufacturers, who state that the results "underscore the chronic character of obesity," similar to managing diseases like hypertension.
Patient Testimonies
People who have come off the jabs report a sudden resurgence of appetite.
"It felt as if a switch flipping and you become starving," said one woman.
This difficulty is compounded if users have not established sustainable lifestyle or habit changes during therapy.
Widespread Use
Figures show that a significant number of adults in the UK have used these injections in the past year, with interest being substantial.
- Use is more common among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Ultimately, experts stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic solution and maintained weight loss hinges on combined behavioural changes.
